1. Home
  2. ORA vs PCVX Comparison

ORA vs PCVX Comparison

Compare ORA & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORA
  • PCVX
  • Stock Information
  • Founded
  • ORA 1965
  • PCVX 2013
  • Country
  • ORA United States
  • PCVX United States
  • Employees
  • ORA N/A
  • PCVX N/A
  • Industry
  • ORA Electric Utilities: Central
  • PCVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORA Utilities
  • PCVX Health Care
  • Exchange
  • ORA Nasdaq
  • PCVX Nasdaq
  • Market Cap
  • ORA 4.6B
  • PCVX 4.4B
  • IPO Year
  • ORA 2004
  • PCVX 2020
  • Fundamental
  • Price
  • ORA $89.47
  • PCVX $34.82
  • Analyst Decision
  • ORA Buy
  • PCVX Strong Buy
  • Analyst Count
  • ORA 8
  • PCVX 10
  • Target Price
  • ORA $91.50
  • PCVX $136.50
  • AVG Volume (30 Days)
  • ORA 459.9K
  • PCVX 1.1M
  • Earning Date
  • ORA 08-06-2025
  • PCVX 08-05-2025
  • Dividend Yield
  • ORA 0.53%
  • PCVX N/A
  • EPS Growth
  • ORA N/A
  • PCVX N/A
  • EPS
  • ORA 2.06
  • PCVX N/A
  • Revenue
  • ORA $885,250,000.00
  • PCVX N/A
  • Revenue This Year
  • ORA $9.30
  • PCVX N/A
  • Revenue Next Year
  • ORA $15.14
  • PCVX N/A
  • P/E Ratio
  • ORA $43.57
  • PCVX N/A
  • Revenue Growth
  • ORA 1.95
  • PCVX N/A
  • 52 Week Low
  • ORA $61.58
  • PCVX $27.66
  • 52 Week High
  • ORA $91.81
  • PCVX $121.06
  • Technical
  • Relative Strength Index (RSI)
  • ORA 62.38
  • PCVX 47.88
  • Support Level
  • ORA $87.61
  • PCVX $35.46
  • Resistance Level
  • ORA $91.81
  • PCVX $37.00
  • Average True Range (ATR)
  • ORA 1.23
  • PCVX 1.43
  • MACD
  • ORA -0.38
  • PCVX -0.14
  • Stochastic Oscillator
  • ORA 59.86
  • PCVX 9.28

About ORA Ormat Technologies Inc.

Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: Electricity Segment. where the company develops, builds, owns and operates geothermal, solar PV and recovered energy-based power plants in the United States and geothermal power plants in other countries and sell the electricity generated. Product Segment includes designing, manufacturing and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement and construction of geothermal and recovered energy-based power plants. Energy Storage Segment includes owning and operating grid-connected which provide capacity, energy and ancillary services directly to the electric grid.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: